Abstract:Background and objectives: Prolonged compound muscle action potential (CMAP) duration and preferential loss of myosin are considered the diagnostic hallmarks of critical illness myopathy (CIM); however, their correlation and prognostic values have not been studied. We aimed to investigate the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss. Methods: We searched the Mayo Clinic Electromyography Laboratory databases (1986-2021) for patients diagnosed with CIM on the basis of prolonged distal CMAP durations (>15 msec in fibular motor nerve studies recording over the tibialis anterior or >8 msec in other motor nerves) and needle EMG findings compatible with myopathy. Electrodiagnostic studies were generally performed within 24 hours after weakness became noticeable. We included only patients who underwent muscle biopsy. Clinical, electrophysiologic, and myopathologic data were reviewed. We conducted myosin/actin ratio analysis when muscle tissue was available. We used the Fisher exact test for categorical data comparisons and the Mann-Whitney 2-tailed test for continuous data. We applied the Kaplan-Meier technique to analyze survival rates. Results: Twenty patients (13 female patients) were identified [median age at diagnosis of 62.5 years (range: 19-80 years)]. The median onset of weakness was 24 days (range: 1-128) from the first day of intensive care unit admission. Muscle biopsy showed myosin loss in 14 patients, 9 of whom had >50% of myofibers affected (high grade). Type 2 fiber atrophy was observed in 19 patients, 13 of whom also had myosin loss. Patients with myosin loss had higher frequency of steroid exposure (14 vs 3; p = 0.004); higher median number of necrotic fibers per low-power field (2.5 vs 1, p = 0.04); and longer median CMAP duration (msec) of fibular (13.4 vs 8.75, p = 0.02), tibial (10 vs 7.8, p = 0.01), and ulnar (11.1 vs 7.95, p = 0.002) nerves compared with those without. Only patients with high-grade myosin loss had reduced myosin/actin ratios (<1.7). Ten patients died during median follow-up of 3 months. The mortality rate was similar between patients with and without myosin loss. Patients with high-grade myosin loss had a lower overall survival rate than those with low-grade or no myosin loss, but this was not statistically significant (p = 0.05). Discussion: Myosin loss occurred in 70% of the patients with CIM with prolonged CMAP duration. Longer CMAP duration predicts myosin-loss pathology. The extent of myosin loss marginally correlates with the mortality rate. Our findings highlight the potential prognostic values of CMAP duration and myosin loss severity in predicting disease outcome.

Clinical, Electrophysiological and Pathologic Features of Critical Illness Polyneuropathy and Myopathy: 3 Cases Report

New Approaches to Critical Illness Polyneuromyopathy: High-Resolution Neuromuscular Ultrasound Characteristics and Cytokine Profiling

Neuromuscular manifestations of critical illness

The clinical, electrophysiological and nerve pathological features of paraneoplastic peripheral neuropathy

The clinical pathological characteristics and follow-up of 4 cases of immune-mediated necrotizing myopathy

Critical illness neuropathy in severe COVID-19: a case series

Acute Mitochondrial Myopathy with Respiratory Insufficiency and Motor Axonal Polyneuropathy.

Neurologic complications of critical illness: part II. Polyneuropathies and myopathies

A prospective clinical study on the mechanisms underlying critical illness myopathy-A time-course approach

Neurological complications of sepsis: critical illness polyneuropathy and myopathy

The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill

Compound Muscle Action Potential and Myosin-Loss Pathology in Patients With Critical Illness Myopathy: Correlation and Prognostication

Recovery and Long Term Functional Outcome in Subjects With Critical Illness Polyneuropathy and Myopathy: a Scoping Review

Characteristics of the Cerebrospinal Fluid in Septic Patients with Critical Illness Polyneuropathy - A Retrospective Cohort Study

Peripheral Neuropathy in Multiple Sclerosis: a Clinical and Electroneurophysiological Study

Patholgo ical and immunohistochemical studies in chronic idiopathic axonal polyneuropathy patients

The study of relationship between clinic and electromyogram in 57 cases of motor neuron disease

Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial

[Neurophysiologic Studies of POEMS Syndrome and Its Related Diseases].

Pulmonary and Physical Rehabilitation in Critically Ill Patients

A Charcot-Marie-Tooth Disease Resembling to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:A Report of Two Cases